Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, Department of Neurology, Knight Alzheimer's Disease Research Center, and Hope Center for Neurological Disorders, Washington University, St. Louis, Missouri 63110, and Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, College of Medicine, Xiamen University, Xiamen 361005, China.
J Neurosci. 2013 Dec 4;33(49):19276-83. doi: 10.1523/JNEUROSCI.3487-13.2013.
Alzheimer's disease (AD) is the most prevalent form of dementia in the elderly population. Accumulation, aggregation, and deposition of amyloid-β (Aβ) peptides generated through proteolytic cleavage of amyloid precursor protein (APP) are likely initiating events in the pathogenesis of AD. While Aβ production is accelerated in familial AD, increasing evidence indicates that impaired clearance of Aβ is responsible for late-onset AD. Because Aβ is mainly generated in neurons, these cells are predicted to have the highest risk of encountering Aβ among all cell types in the brain. However, it is still unclear whether they are also involved in Aβ clearance. Here we show that receptor-mediated endocytosis in neurons by the low-density lipoprotein receptor-related protein 1 (LRP1) plays a critical role in brain Aβ clearance. LRP1 is known to be an endocytic receptor for multiple ligands including Aβ. Conditional knock-out of Lrp1 in mouse forebrain neurons leads to increased brain Aβ levels and exacerbated amyloid plaque deposition selectively in the cortex of amyloid model APP/PS1 mice without affecting Aβ production. In vivo microdialysis studies demonstrated that Aβ clearance in brain interstitial fluid is impaired in neuronal Lrp1 knock-out mice. Because the neuronal LRP1-deletion did not affect the mRNA levels of major Aβ degrading enzymes, neprilysin and insulin-degrading enzyme, the disturbed Aβ clearance is likely due to the suppression of LRP1-mediated neuronal Aβ uptake and degradation. Together, our results demonstrate that LRP1 plays an important role in receptor-mediated clearance of Aβ and indicate that neurons not only produce but also clear Aβ.
阿尔茨海默病(AD)是老年人中最常见的痴呆症形式。淀粉样β(Aβ)肽的积累、聚集和沉积是通过淀粉样前体蛋白(APP)的蛋白水解切割产生的,可能是 AD 发病机制的起始事件。虽然家族性 AD 中 Aβ的产生加速,但越来越多的证据表明 Aβ的清除受损是导致迟发性 AD 的原因。由于 Aβ主要在神经元中产生,因此这些细胞在大脑中所有细胞类型中遇到 Aβ的风险最高。然而,目前尚不清楚它们是否也参与 Aβ的清除。在这里,我们表明神经元中低密度脂蛋白受体相关蛋白 1(LRP1)的受体介导内吞作用在大脑 Aβ清除中起关键作用。LRP1 是多种配体(包括 Aβ)的内吞受体。在小鼠前脑神经元中条件性敲除 Lrp1 会导致大脑 Aβ水平升高,并选择性地加剧淀粉样斑块沉积在 APP/PS1 淀粉样模型小鼠的皮质中,而不影响 Aβ的产生。体内微透析研究表明,神经元 Lrp1 敲除小鼠脑间质液中 Aβ的清除受损。由于神经元 LRP1 缺失不影响主要 Aβ降解酶 Neprilysin 和胰岛素降解酶的 mRNA 水平,因此 Aβ清除的紊乱可能是由于 LRP1 介导的神经元 Aβ摄取和降解受到抑制。总之,我们的结果表明 LRP1 在 Aβ的受体介导清除中起重要作用,并表明神经元不仅产生 Aβ,而且还清除 Aβ。